Background
==========

Heatstroke (HS) is a life-threatening condition characterized by an elevation of the core body temperature above 40°C, central nervous system dysfunction, and possible multi-organ failure \[[@b1-amjcaserep-18-1058]\].

HS is divided into "classic" (non-exertional) and "exertional" forms. Classic HS is a condition primarily affecting the elderly and those with chronic illness. It is caused by environmental exposure and results in core hyperthermia \[[@b1-amjcaserep-18-1058]\]. Exertional HS is exercise-induced and usually affects healthy younger people as such as athletes and soldiers during strenuous exercise in a warm environment \[[@b2-amjcaserep-18-1058]\].

HS is associated with increasing mortality, with the most dramatic burden during heat waves, defined as at least 2 consecutive days with average daily temperatures exceeding the 99^th^ percentile of the distribution of daily temperature for that location \[[@b3-amjcaserep-18-1058]\].

HS develops through complex and incompletely defined mechanisms; they include direct cytotoxic effects of the high temperature and the activation of sepsis-like inflammatory cascades \[[@b4-amjcaserep-18-1058]\].

HS can trigger systemic inflammation and multi-organ failure. Manifestations of organ damage include: central nervous system damage (loss of consciousness, delirium, cerebral edema, seizures, coma), coagulopathy (disseminated intra vascular coagulation, DIC, bleeding from different sites), liver and renal dysfunction, rhabdomyolysis, respiratory failure (principally pulmonary edema and eventually progression to acute respiratory distress syndrome), and heart complications (arrhythmia, hypovolemic shock) \[[@b4-amjcaserep-18-1058],[@b5-amjcaserep-18-1058]\].

[Figure 1](#f1-amjcaserep-18-1058){ref-type="fig"} is a schematic overview of the possible multi-organ damage due to HS (both exertional and non-exertional).

In this paper, we report the case of a young traveller who experienced severe non-exertional HS, who survived with complete recovery at discharge. Additionally, we discuss the complex pathophysiological mechanisms involved in HS.

Case report
===========

A 41-year-old Romanian female was found lying unconscious on a sidewalk in the center of Verona, Italy. It was a hot, sunny afternoon in June 2016, at 4: 00 PM. The outside temperature was 36.5°C, humidity was 75%, and the heat index (a numerical value obtained by a mathematical operation using temperature and humidity levels) was 57. When the heat index is \>54, HS is extremely likely to occur \[[@b6-amjcaserep-18-1058]\].

The woman was alone, with an old and shabby suitcase, with her passport inside.

Some pedestrians noticed the woman lying on the ground and called the ambulance.

The paramedics found her to be severely hypotensive, with unrecordable blood pressure. She was perspiring profusely, tachycardic (heart rate 150 beats per min), with a temperature of 41°C (tympanic temperature), a Glasgow Coma Score of 3, and peripheral oxygen saturation 89% (without oxygen support). A peripheral line was inserted and cooling measures were initiated applying tepid water to the patient, fanning her to prompt evaporative cooling, and applying ice packs to her neck, axillae, and groin. Then, she was intubated and rushed immediately to the Emergency Department of the University Hospital of the city. Evaporative cooling was maintained during transit. On admission, preliminary blood investigations were made, and she was then admitted to the intensive Care Unit of the same hospital.

The blood laboratory data on arrival at the Emergency Room (Day 1) were the following (nv: normal values): Hemoglobin 13 g/dL (nv 12--14), Hematocrit 38% (nv 35--47), WBC 4340 10^3^/mm^3^ (nv 4300--10000), PLT 102000 per mm3 (nv 150000--400000), Glucose 120 mg/dL (nv 63--99), Creatinine 0.7 mg/dL (nv 0.4--1.1), Sodium 139 mEq/L (nv 135--145), Potassium 4.5 mEq/L (nv 3.4--4.8), Calcium 2.3 mmol/L (nv 8.4--10.4), C Reactive Protein 3 mg/L (nv \<5), PT/INR (nv 0.8--1.1), Fibrinogen 185 mg/dL (nv 200--400), APTT 0.7 (nv 0.8--1.2), ALT 107 U/L (nv 6--50), Total Bilirubin 1mg/dL (nv 0.11--1), Arterial pH 7.1 (nv 7.35--7.45), PCO2 49 mmHg (nv 35--40), PO2 71 mmHg (nv 80--100), HCO3--17 mmol/L (nv 24--28), Troponin T 184 ng/L (nv 2--14), D-Dimer 2964 ug/L (nv \<500), CPK 183 U/L (nv 30--200), and Myoglobin 1111ug/L (nv 25--58).

Then, causes of acute liver failure were ruled-out: no serological findings of A-B-C hepatitis viruses nor Human Immunodeficiency Virus, Cytomegalic virus, Herpes simplex, Epstein-Barr, or Leptospira. The autoimmune antibodies (ANA, ds-DNA, ANCA, ASMA, LKM, mitochondrial antibodies) were tested and found to be negative. Serum levels of transferrin, iron, alpha-1 antitrypsin, protein electrophoresis, feto-protein, ceruloplasmin, and copper (both serum and 24-h urine) gave no pathological findings.

Other findings included macrocytic anemia (mean corpuscular volume 115 fL), vitamin B 12 deficiency (B12 90 pmol/L), normal tyroid function, and normal glucose and lipid values. Ferritin was elevated at 515 μg/L. The urinalysis revealed reddish-brown urine, highly positive for myoglobin.

No significant previous medical history was reported. No herbal supplements or wild mushrooms consumption was reported. BMI was 27 kg/m^2^.

Nevertheless, signs of alcoholic hepatitis were present: the ratio between the serum levels of aspartate transaminase (AST) and alanine transaminase (ALT), the so-called De Ritis ratio, was \>2 \[[@b7-amjcaserep-18-1058]\].

Abdominal ultrasound, including duplex sonography, demonstrated hepatic steatosis but excluded portal vein thrombosis, without evidence of dilated bile ducts. FibroScan technique excluded significant hepatic fibrosis.

Tracheal intubation and mechanical ventilation was needed. Continuous central venous pressure was detected. The target of 8 to 12 mmHg was obtained and maintained \[[@b8-amjcaserep-18-1058]\].

Continuous core temperature was monitored with a rectal probe and cooling measures continued until a temperature of 38° to 39° was achieved (to avoid iatrogenic hypothermia) \[[@b9-amjcaserep-18-1058]\].

Crystalloid solution was used at an infusion rate able to maintain urine output at 200--300 ml/h. Coagulation factors (fresh frozen plasma and prothrombin complex) were replenished. Replenishment of platelets was made because uterine bleeding (menstruation) was in process. This condition of active bleeding posed an even greater risk of hemoglobin and platelets lowering. Antithrombotic stockings were used.

Cranial Computerized Tomography examination excluded intracranial hemorrhage.

Non-specific ST-T changes appeared on the electrocardiogram and seizures became evident and were treated with benzodiazepines. A nasogastric feeding tube was placed to avoid aspiration pneumonia.

The patient regained consciousness on day 2 after the onset of coma. Antibiotic treatment with piperacillin-tazobactam was started. Then, the patient was weaned of the ventilator and extubated.

After 2 days, the patient was transferred from the Intensive Care Unit to the Internal Medicine Department.

A complete medical history was collected. The main finding was 50 g/day alcohol consumption for at least the last 3 years. Then the Alcohol Use Disorders Inventory test (AUDIT, the gold standard tool to screen alcohol abuse \[[@b10-amjcaserep-18-1058]\]) was used to confirm her addiction.

The severity of her disease was assessed with the Model for End-stage Liver Disease (MELD) \[[@b11-amjcaserep-18-1058]\]. The calculated score (considering INR 2.9, total bilirubin 10 mg/dL and creatinine 1.3 mg/dL) was 30 (90-day mortality: 52--60%). Then, pharmacological and motivational support were started, according to the current guidelines in the management of alcoholic liver disease \[[@b12-amjcaserep-18-1058]\]. Sodium Oxybate (Alcover) treatment was started (Disulfiram was avoided because of its hepatotoxicity in the context of the current acute hepatitis). She also indicated she smoked 15--20 cigarettes/day). The Fageström test for nicotine dependence \[[@b13-amjcaserep-18-1058]\] was used to better understand her smoking history and status. Nicotine dependence was high (Fageström score: 8 points). The nicotine substitution by trans-dermic patch was applied. The patients did not experience withdrawal syndrome and was sustained with motivational psychological support.

[Table 1](#t1-amjcaserep-18-1058){ref-type="table"} depicts the time-course of blood laboratory data from day 2 to day 30 after the acute event.

After 17 days, the patient was discharged home (in Italy) with an early outpatient follow-up. Laboratory data were tested after 1 month after the acute event. The patient was clinically stable with complete normalization of laboratory parameters. However, she did not continue the follow-up proposed by the Addiction Unit of the hospital. The woman confirmed that she had stopped drinking and smoking, but this was impossible to verify.

Discussion
==========

We report the case of a woman with history of alcohol addiction who had severe non-exertional HS with multi-organ failure after arrival in Italy by bus. Her complete and prompt recovery is described.

The exact mechanism of HS-related multiple organ dysfunction is not completely understood, but it is clear that its pathogenesis is complex.

An interesting preclinical detailed model of HS exposed mice to high temperature \[[@b14-amjcaserep-18-1058]\]. It was created to clarify the pathophysiology of HS and it is the first model of HS in mice that resembles human HS. The authors demonstrated multi-organ histological damage in mice. Random samples of liver, kidney, and small intestine were obtained. The tissues showed visible vascular congestion, thrombi, and hemorrhage zones. The liver was found to be the most vulnerable organ, as a result both of hypoxia and direct heat damage. Liver enzymes are very sensitive markers of the organ damage. This was different from renal failure. In fact, in the presence of histological renal damage, serum creatinine and blood urea nitrogen did not rise accordingly to the degree of damage. The intestinal barrier has been shown to be a consistent target of injury during HS. In particular, intestinal and liver damage can lead to the release of endotoxin and other inflammatory mediators into the blood. The intestinal injury may be so extensive in HS (in the duodenum, jejunum, and ileum), that the epithelial cells lining the intestinal walls may not have recovered sufficiently to begin an effective repair process.

Acute liver damage with fulminant hepatic failure is a frequently reported complication of HS, with some cases requiring liver transplantation \[[@b15-amjcaserep-18-1058]\]. The ultra-structural changes in human liver after HS had been described from many years \[[@b16-amjcaserep-18-1058]\]. These features consist of degenerative changes of sinusoidal lining cells and breaks in hepatocyte outer membranes. Other alterations include vesiculation of endoplasmic reticulum (ER), detachment of ribosomes, and alterations of mitochondria. Liver failure appears to be linked to intestinal ischemia. Intestinal microcirculatory disturbances, in the context of DIC, contribute to the damage.

There are no established indications for liver transplantation in acute liver failure due to HS. Some studies showed successful conservative treatment \[[@b17-amjcaserep-18-1058]\], but this point remains a medical dilemma, as explained previously \[[@b18-amjcaserep-18-1058]\]. Patients receiving liver transplantation after HS may either die \[[@b19-amjcaserep-18-1058],[@b20-amjcaserep-18-1058]\] or survive \[[@b21-amjcaserep-18-1058]\]. HS is a clinical condition in which application of the current guidelines \[[@b22-amjcaserep-18-1058]\] for liver transplantation is not easy because of multi-organ involvement, persistent hyperthermia, and renal failure and the fact that several features of HS are not covered in the guideline criteria \[[@b22-amjcaserep-18-1058]\].

Several reports (as well as the present one) describe the presence of severe hypophosphatemia upon admission \[[@b23-amjcaserep-18-1058],[@b24-amjcaserep-18-1058]\]. This value has been linked to the severity of liver damage. Hypophosphatemia has been observed in conditions of fever and hyperthermia, but the precise mechanisms in HS are still elusive. Some explanations have been suggested. Hypophosphatemia could be related to the respiratory alkalosis induced by hyperthermia, which causes the shifting of phosphorus from the extracellular to the intracellular compartment. Alternatively, the elevation of body temperature increases the intracellular phosphate utilization in the glycolytic pathway, causing phosphorus to shift from the extracellular fluid into the cells. A reduced synthesis of adenosine tri-phosphate and decreased red cells 2,3-diphosphoglycerate may lead to lower liver oxygenation and, finally, impaired liver perfusion \[[@b25-amjcaserep-18-1058]\]. The presence of profound hypophosphatemia upon admission seems to be associated with development of acute liver failure.

DIC is a common feature in HS. It is characterized by the widespread activation of coagulation, resulting in intravascular formation of fibrin and thrombotic occlusion of little and middle vessels \[[@b26-amjcaserep-18-1058]\]. Findings consistent with acute DIC include thrombocytopenia, prolonged PT and APTT, low plasma fibrinogen, elevated plasma D-dimer, reduced levels of pro-coagulant factors, and micro-angiopathic changes on peripheral blood smear. None of them is highly specific for DIC, and no single laboratory test can accurately confirm or exclude the diagnosis. Treatment of DIC is carefully discussed in the current guidelines \[[@b27-amjcaserep-18-1058],[@b28-amjcaserep-18-1058]\]. To summarize the main concepts, a major principle in the management of DIC is the treatment of the underlying cause with the aim to eliminate the stimulus for ongoing coagulation and thrombosis. Moreover, for patients who are not bleeding, as long as the platelets count is ≥10 000/mL, there is no indication to use prophylactic administration of platelets and coagulation factors. In the current case report, we supported the patient with platelets infusion and plasma because of uterine bleeding (menstruation).

HS causes also rhabdomyolysis. The classic presentation of rhabdomyolysis consists of myalgias, limb weakness, and pigmenturia due to myoglobinuria without hematuria. The hallmark is the elevation of creatine kinase and liver enzymes. Acute renal failure is the most dangerous complication of rhabdomyolysis, with a high mortality rate \[[@b29-amjcaserep-18-1058]\].

Several cardiac complications have been also documented in HS \[[@b30-amjcaserep-18-1058]\]. Electrocardiogram abnormalities (sinus tachycardia, ST-T elevation, T wave abnormalities, and QT interval prolongation) have been recognized. Transient high serum levels of myocardial damage markers and altered global cardiac systolic function by cardiac ultrasound have been found.

As with our patient, these abnormalities are reversed after proper cooling treatment. Nevertheless, the pathophysiology of cardiac involvement is not completely understood. Endothelial coronary damage could be a factor involved, as proposed, because of the elevation of circulating endothelin and intracellular adhesion molecule-1 in HS patients \[[@b31-amjcaserep-18-1058]\]. These cardiac abnormalities have been also matched with the so-called Tako-Tsubo cardiomyopathy \[[@b30-amjcaserep-18-1058]\], but without precise causative elements.

All cited case reports and review articles agree that the severity and complications of HS correlate with the temperature duration curve. A rapid reduction in the core temperature by any cooling method, as early as possible, is the main effector of good prognosis. Evaporative cooling is one of the preferred cooling method. It is safe, effective, easily accomplished. It consists in undressing the patient, spraying tepid water, and cooling by large fans to maximize evaporative heat loss. Cooling by immersion in ice water is the most rapid method of reducing core temperature, but is not always well tolerated. Intravascular cooling systems have been described as efficacious and feasible methods. Salicylates and acetaminophen should be avoided, because they are ineffective and potentially dangerous for the liver \[[@b32-amjcaserep-18-1058]--[@b34-amjcaserep-18-1058]\].

Clinical and experimental data suggest that the pathophysiological response to HS is the result of a systemic inflammatory response. Concentration of cytokines, both pro- and anti-inflammatory ones (IL-1, IL-6, IL-1β, IL-10, TNFα, IFNγ), have been shown to be elevated in HS patients, as such as Reactive Oxygen Species (ROS) and heat shock proteins (HSPs) \[[@b35-amjcaserep-18-1058],[@b36-amjcaserep-18-1058]\]. The liver is the main organ involved in the production and response to cytokines during inflammation. All these findings reveal a complex network of interactions that orchestrates the inflammatory response in HS. Animal and human data demonstrate that plasma concentration of such cytokines increase in a time- and core temperature-dependent manner \[[@b35-amjcaserep-18-1058],[@b37-amjcaserep-18-1058],[@b38-amjcaserep-18-1058]\], and they could be considered as possible markers of HS prognosis \[[@b39-amjcaserep-18-1058],[@b40-amjcaserep-18-1058]\].

Rats exposed to environmental heat have an increase of HSP-72 in most organs, proportional to the severity of the heat stress. In humans, exertional HS has been shown to be a potent inducer of HSP-72 expression \[[@b41-amjcaserep-18-1058]\]. In baboons subjected to HS \[[@b40-amjcaserep-18-1058]\], the markers of cell injury and organ dysfunction significantly correlated with HSP-72 levels. Circulating HSP-72 may indicate the extent of tissue damage. Circulating levels of HSP-72 and HSP-60 were found markedly elevated in patients with severe HS and were associated with increased morbidity and mortality \[[@b42-amjcaserep-18-1058]\]. A protective effect of HSP-72 has been proposed \[[@b43-amjcaserep-18-1058]\].

Then, the discussion could be driven toward a peculiar field of research with the aim to include a possible explanation of the quick and complete recovery in this alcohol-addicted patient.

In this perspective, a great limitation of this case report is the lack of collection of data about oxidative stress markers and hypothetically-related gene expression, in particular the transcriptional pro-inflammatory factor nuclear factor κB (NF-κB). So, these considerations are elusive for the present case.

It has been demonstrated that increased production of ROS is directly involved in oxidative damage during HS \[[@b44-amjcaserep-18-1058]\]. In particular, brain injury seems to be greatly related to oxidative stress damage in HS. The pathophysiological mechanisms underlying cerebral injury resulting from increasing oxidative stress are not completely elucidated. Oxygen radicals, because of their reactivity, can injure neurons and other brain cells directly. Nevertheless, the redox signalling of oxygen radicals targets mitochondrial cytochrome c release, DNA repair enzyme, and NF-κB, which may lead to neuronal damage \[[@b45-amjcaserep-18-1058]\]. NF-κB is the central regulator of innate and adaptive response with hundreds of target genes, some with pro-inflammatory effects and some promoting cell survival \[[@b46-amjcaserep-18-1058],[@b47-amjcaserep-18-1058]\]. Normally held in the cytoplasm in complex with the inhibitor-κBα (IκBα), canonical activation of NF-κB involves phosphorylation of IκBα and its proteasome degradation when inflammation occurs \[[@b48-amjcaserep-18-1058]\].

Both high temperature and hypoxia can impair mitochondrial function. It has been demonstrated \[[@b49-amjcaserep-18-1058]\] that high temperature and exercise cause morphology changes in the inner structure of mitochondria in cardiomyocytes and hepatocytes derived from rats subjected to HS. This process happens with an over-generation of ROS, and a subsequent activation of NF-κB.

Chronic alcohol intake causes inflammatory response, with ROS generation, subsequent NF-kB activation, and cytokines production \[[@b50-amjcaserep-18-1058]\]. ROS are also implicated in fibrosis progression due to alcoholic steato-hepatitis \[[@b51-amjcaserep-18-1058]\]. Alcoholism can be considered a systemic pro-inflammatory condition in which Kupffer cells and macrophages play the major role in the development and progression of the disease \[[@b52-amjcaserep-18-1058]\].

The intriguing point is the multi-faceted role of NF-κB, in particular its protective role, as emerged in different studies mentioned below. This fact opens a debate between the deleterious and protective role of this transcription factor. In fact, NF-κB is able to induce the expression of several survival proteins, including c-IAP1 and 2, TRAF-1, and 2 \[[@b53-amjcaserep-18-1058]--[@b56-amjcaserep-18-1058]\].

NF-κB protective action has been shown to be related to the cross-talk with HSPs, normally involved in protection against apoptosis \[[@b57-amjcaserep-18-1058],[@b58-amjcaserep-18-1058]\].

It has been demonstrated that acute or short-term alcohol administration is able to activate NF-κB in the brain \[[@b59-amjcaserep-18-1058]\]. Animal studies demonstrated that acute alcohol exposure transiently activates NF-κB. NF-κB plays a critical role in the acquisition of alcohol resistance by maturing neurons \[[@b60-amjcaserep-18-1058]\]. In fact, alcohol-induced damage to the developing brain leads to fetal alcohol syndrome. However, in mature neurons this results in acquisition of resistance to ethanol. This process apparently involves the protective nitric oxide-cyclic GMP-dependent protein kinase pathway G. NF-κB was found as a downstream effector through which this pathway signals its neuroprotective effects against alcohol.

We speculate that the quick restoration of our patient's liver function after HS could be somehow be related to adaptive responses partly related to NF-κB activation. This is due to the patient's alcoholic addiction. According to this hypothesis, other protective mechanisms have been investigated.

Lugea et al. \[[@b61-amjcaserep-18-1058]\] studied the role of the unfolded protein response (UPR) in pancreatic response in alcohol abuse.

Proteins usually enter the ER as "unfolded" polypeptides \[[@b62-amjcaserep-18-1058]\]. ER transmembrane sensors detect the accumulation of the unfolded proteins and activate transcriptional and translational pathways that deal with the unfolded and misfolded proteins. This is known as the UPR \[[@b62-amjcaserep-18-1058]\].

However, the failure to relieve prolonged or severe ER stress is the cause of the cell apoptotic death \[[@b62-amjcaserep-18-1058]\]. When ER stress occurs, ER transmembrane sensors are activated to initiate adaptive responses \[[@b63-amjcaserep-18-1058]\]. Once the UPR fails to control the level of unfolded and misfolded proteins in the ER, ER-initiated apoptotic signalling is induced with the activation of death factors. The UPR applies several mechanisms to minimize ER stress.

Among ER stress sensors, IRE1 is the most evolutionarily conserved. In normal conditions, IRE1 interacts with GRP78/BiP and prevents IRE1 activation \[[@b63-amjcaserep-18-1058]\]. The activated IRE1 specifically splices mRNA, encoding Xbox binding protein (XBP)1, and so inducing the activation of XBP1 \[[@b64-amjcaserep-18-1058]\]. XBP1 increases the transcription of chaperones and other UPR-related proteins and enhances the degradation of the misfolded proteins. In this context, Lugea et al. \[[@b61-amjcaserep-18-1058]\] demonstrated that sXBP1 is a key protective factor against ethanol-induced toxicity in the pancreas.

To conclude, some functions of ER stress are adaptive, while others are maladaptive, and it is likely that it is the degree and length of the insult that discriminate between cell survival or death, as has also been discussed in other pathological contexts \[[@b65-amjcaserep-18-1058]\]. In this circumstance, the degree and the length of ethanol damage may be the discriminating factor between cell survival or death. Nevertheless, this hypothesis has to be further investigated.

HS is a life-threatening condition. Severe multi-organ damage can complicate HS.

Rapid cooling and management of circulatory failure are crucial to the prevention of irreversible tissue damage and death in HS. HS is manageable and patients may heal completely. It is mandatory to promptly recognize signs and symptoms of HS. Predisposing factors such as drugs or alcohol should always be suspected, as also shown in a recent case report \[[@b66-amjcaserep-18-1058]\].

Although the exact mechanism of HS -related multiple organ dysfunction is not completely understood, it is clear that its pathogenesis is complex.

Conclusions
===========

The model in which history of alcohol addiction alters oxidative, inflammatory, and ER stress response could be a conceivable solution to the positive prognosis of HS patients.
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###### 

Time-course of blood laboratory data from the day 2 to the day 30 after the acute event.

  **Blood laboratory data**           **Day 2**   **Day 4**   **Day 5**   **Day 6**   **Day 8**   **Day 12**   **Day 17 discharge**   **Day 30 follow-up**
  ----------------------------------- ----------- ----------- ----------- ----------- ----------- ------------ ---------------------- ----------------------
  Haemoglobin g/dL (nv 12--14)        11.7        11.5        10.9        9.2         8           9            10                     11
  Hematocrit% (nv 35--47)             35          34          33          26          25          28           32                     33
  MCV fL (nv 86--98)                  112         111         115         108         111         115          116                    101
  WBC 10^3^/mm^3^ (nv 4300--10000)    5360        3220        4260        3940        3390        3140         3910                   4000
  PLT per mm^3^ (nv 150000--400000)   59000       14000       15000       46000       148000      226000       401000                 400000
  Glucose mg/dL (nv 63--99)           127         90          80          --          --          --           80                     82
  Creatinine mg/dL (nv 0.4--1.1)      1.3         0.9         0.8         0.6         --          0.5          0.5                    0.5
  Sodium mEq/L (nv 135--145)          143         140         146         141         --          --           140                    140
  Potassium mEq/L (nv 3.4--4.8)       3.4         4           --          --          3.4         --           3.4                    3.5
  Phosphates mg/dL (nv 2.6--4.4)      1.54        --          --          --          --          3            --                     --
  PT/INR (nv 0.8--1.1)                1.09        2           2.9         2.7         2           1.5          1                      1
  Fibrinogen mg/dL (nv 200--400)      150         150         160         200         200         300          300                    --
  APTT (nv 0.8--1.2)                  0.8         1           0.9         0.9         1           1            1                      --
  ALT U/L (nv 6--50)                  1279        1823        1695        1130        700         413          70                     40
  AST U/L (nv 5--50)                  3000        4252        3000        1696        680         91           41                     40
  GGT U/L (nv 4--45)                  400         350         --          --          250         150          --                     90
  Tot. Bilirubin mg/dL (nv 0.11--1)   2           7           10          6           4           --           3                      3
  Direct Bilirubin mg/dL              1.5         5           9           5           --          --           --                     --
  Ammonium ug/dL (nv 18--77)          70          --          --          --          --          --           20                     --
  Arterial pH (nv 7.35--7.45)         7.2         7.3         --          --          7.46        --           --                     --
  PCO~2~ mmHg (nv 35--40)             49          45          --          --          37          --           --                     --
  PO~2~ mmHg (nv 80--100)             74          88          --          --          90          --           --                     --
  HCO~3−~ mmol/L (nv 24--28)          18          18          --          --          25          --           --                     --
  D-Dimer ug/L (nv \<500)             2900        --          --          --          --          --           --                     --
  CPK U/L (nv 30--200)                1391        --          1000        --          --          400          190                    --
  Myoglobin ug/L (nv 25--58)          1200        1000        --          --          --          115          48                     --
  Albumin g/L (nv 35--50)             33          --          --          --          --          --           35                     --
  CRP mg/L (nv 30--200)               \<3         9           11          6           --          --           3                      \<3
  Procalcitonin ng/mL (nv \<0.05)     0.2         2.8         --          2.7         --          --           0.9                    --
  LDH U/L (nv 85--245)                1438        2198        834         641         480         --           300                    --

MCV -- mean corpuscular volume; WBC -- white blood cells; PLT -- platelets; PT/INR: prothrombin time; APTT -- partial thromboplastin time; ALT -- alanine aminotransferase; AST -- aspartate aminotransferase; GGT -- gamma glutamyl transferase; CRP -- C reactive protein; CPK -- creatine phosphokinase; LDH -- lactate dehydrogenase; nv -- normal values.
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